AR015947A1 - Una forma 1 polimorfica (-)-4-[4-[4-[4-[[(2r-cis]-5-(2,4-difluorfenil)tetrahidro-5-(1h-1,2,4-triazol-1-ilmetil)furan-3-il]-metoxi]fenil]-1-piperazinil]fenil-2,4-dihidro-2-[(s)-1-etil-2-(s)-hidroxipropil]-3h-1,2,4-triazol-3-ona, composicion farmaceutica que la contiene y su uso para preparar un medic - Google Patents

Una forma 1 polimorfica (-)-4-[4-[4-[4-[[(2r-cis]-5-(2,4-difluorfenil)tetrahidro-5-(1h-1,2,4-triazol-1-ilmetil)furan-3-il]-metoxi]fenil]-1-piperazinil]fenil-2,4-dihidro-2-[(s)-1-etil-2-(s)-hidroxipropil]-3h-1,2,4-triazol-3-ona, composicion farmaceutica que la contiene y su uso para preparar un medic

Info

Publication number
AR015947A1
AR015947A1 ARP980104957A ARP980104957A AR015947A1 AR 015947 A1 AR015947 A1 AR 015947A1 AR P980104957 A ARP980104957 A AR P980104957A AR P980104957 A ARP980104957 A AR P980104957A AR 015947 A1 AR015947 A1 AR 015947A1
Authority
AR
Argentina
Prior art keywords
triazol
phenyl
furan
tetrahydro
dihydro
Prior art date
Application number
ARP980104957A
Other languages
English (en)
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR015947A1 publication Critical patent/AR015947A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ARP980104957A 1997-10-07 1998-10-05 Una forma 1 polimorfica (-)-4-[4-[4-[4-[[(2r-cis]-5-(2,4-difluorfenil)tetrahidro-5-(1h-1,2,4-triazol-1-ilmetil)furan-3-il]-metoxi]fenil]-1-piperazinil]fenil-2,4-dihidro-2-[(s)-1-etil-2-(s)-hidroxipropil]-3h-1,2,4-triazol-3-ona, composicion farmaceutica que la contiene y su uso para preparar un medic AR015947A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94618397A 1997-10-07 1997-10-07

Publications (1)

Publication Number Publication Date
AR015947A1 true AR015947A1 (es) 2001-05-30

Family

ID=25484068

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104957A AR015947A1 (es) 1997-10-07 1998-10-05 Una forma 1 polimorfica (-)-4-[4-[4-[4-[[(2r-cis]-5-(2,4-difluorfenil)tetrahidro-5-(1h-1,2,4-triazol-1-ilmetil)furan-3-il]-metoxi]fenil]-1-piperazinil]fenil-2,4-dihidro-2-[(s)-1-etil-2-(s)-hidroxipropil]-3h-1,2,4-triazol-3-ona, composicion farmaceutica que la contiene y su uso para preparar un medic

Country Status (30)

Country Link
EP (1) EP1021439B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (4) JP2001519346A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100626109B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1125067C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR015947A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE263163T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU759982B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9812866A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2305803C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CO (1) CO4970829A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CZ (1) CZ299835B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69822859T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK1021439T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2217594T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU225233B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ID (1) ID29290A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL135331A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IN (1) IN1998CH02232A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX225999B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY130126A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO318827B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ503662A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PE (1) PE120499A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH11998002606B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL189317B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT1021439E (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SK (1) SK285190B6 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW589310B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1999018097A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA989063B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
US20120101277A1 (en) 2009-07-09 2012-04-26 Sandoz Ag Crystalline form of posaconazole
WO2011144655A1 (en) 2010-05-19 2011-11-24 Sandoz Ag Process for the preparation of chiral hydrazides
BR112012029228A2 (pt) 2010-05-19 2021-08-03 Sandoz Ag processo para a preparação de um sal de cloreto de hidrogênio, sal de cloreto de hidrogênio, sal de cloreto de hidrogênio cristalino, uso de um sal e uso do processo
MX338514B (es) 2010-05-19 2016-04-20 Sandoz Ag Preparacion de intermediarios de posaconazol.
RU2585760C2 (ru) * 2010-05-19 2016-06-10 Сандоз Аг Способ получения хиральных триазолонов
CN103635465A (zh) 2011-06-16 2014-03-12 桑多斯股份公司 制备手性化合物的方法
US9102664B2 (en) 2011-09-19 2015-08-11 Msn Laboratories Private Limited Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof
US9670188B2 (en) 2013-07-25 2017-06-06 Sandoz Ag Process for the preparation of crystalline form IV of posaconazole
ITMI20132115A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132114A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132117A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
ITMI20132118A1 (it) * 2013-12-18 2015-06-19 Djada Pharmaceutical Sa Una forma cristallina di posaconazolo
CN104370894A (zh) * 2014-10-21 2015-02-25 江苏恒盛药业有限公司 无定型泊沙康唑的制备工艺
CN104387374A (zh) * 2014-10-21 2015-03-04 江苏恒盛药业有限公司 泊沙康唑晶型i的制备工艺
EA035145B1 (ru) 2014-10-21 2020-05-06 Ариад Фармасьютикалз, Инк. Кристаллические формы 5-хлор-n4-[2-(диметилфосфорил)фенил]-n2-{2-метокси-4-[4-(4-метилпиперазин-1-ил)пиперидин-1-ил]фенил}пиримидин-2,4-диамина
WO2017025292A1 (en) 2015-08-08 2017-02-16 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Gastro-resistant formulation containing posaconazole
EA039213B1 (ru) 2015-12-24 2021-12-17 Такеда Фармасьютикал Компани Лимитед Сокристалл, способ его получения и лекарственное средство, содержащее сокристалл
EP4424308A3 (en) 2016-02-26 2024-12-04 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole and a polymeric precipitation inhibitor
CN105949278B (zh) * 2016-03-30 2019-12-06 南京曼杰生物科技有限公司 一种取代的四氢呋喃水溶性衍生物及其应用
WO2017032908A1 (en) 2016-07-08 2017-03-02 Synthon B.V. Pharmaceutical composition comprising amorphous posaconazole
TR201620462A2 (tr) 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
TR201722493A2 (tr) 2017-12-28 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
EP4196096A1 (en) 2020-08-13 2023-06-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant high-strength formulation containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
WO2023012378A1 (en) 2021-11-25 2023-02-09 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103558A0 (en) * 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
CO4520281A1 (es) * 1993-12-21 1997-10-15 Schering Corp Antifungicos de tetrahidrofurano
EP0741737B1 (en) * 1994-01-24 1999-11-10 Janssen Pharmaceutica N.V. Watersoluble azole antifungals
US5625064A (en) * 1995-04-19 1997-04-29 Schering Corporation Process for the preparation of triazolones
CN1073109C (zh) * 1995-06-02 2001-10-17 先灵公司 四氢呋喃杀真菌剂

Also Published As

Publication number Publication date
CZ20001264A3 (cs) 2000-08-16
KR20010030959A (ko) 2001-04-16
TW589310B (en) 2004-06-01
JP2012153729A (ja) 2012-08-16
JP2001519346A (ja) 2001-10-23
AU759982B2 (en) 2003-05-01
PT1021439E (pt) 2004-07-30
DE69822859D1 (de) 2004-05-06
HUP0004899A2 (hu) 2002-02-28
MY130126A (en) 2007-06-29
IN1998CH02232A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2005-03-04
CA2305803C (en) 2009-12-22
SK285190B6 (sk) 2006-08-03
PH11998002606B1 (en) 2006-08-10
WO1999018097A1 (en) 1999-04-15
PL339659A1 (en) 2001-01-02
CO4970829A1 (es) 2000-11-07
NO20001779D0 (no) 2000-04-06
CZ299835B6 (cs) 2008-12-10
EP1021439B1 (en) 2004-03-31
DK1021439T3 (da) 2004-05-10
NO20001779L (no) 2000-06-06
ES2217594T3 (es) 2004-11-01
JP2008106075A (ja) 2008-05-08
DE69822859T2 (de) 2005-01-27
AU9780398A (en) 1999-04-27
MX225999B (es) 2005-02-02
PL189317B1 (pl) 2005-07-29
IL135331A (en) 2005-08-31
SK5122000A3 (en) 2000-09-12
CN1281449A (zh) 2001-01-24
NZ503662A (en) 2002-10-25
NO318827B1 (no) 2005-05-09
CN1125067C (zh) 2003-10-22
HK1029588A1 (en) 2001-04-06
CA2305803A1 (en) 1999-04-15
IL135331A0 (en) 2001-05-20
ATE263163T1 (de) 2004-04-15
ZA989063B (en) 1999-04-06
EP1021439A1 (en) 2000-07-26
BR9812866A (pt) 2000-08-08
PE120499A1 (es) 1999-12-04
HUP0004899A3 (en) 2002-03-28
MXPA00003404A (es) 2000-11-01
ID29290A (id) 2001-08-16
KR100626109B1 (ko) 2006-09-20
JP2012153730A (ja) 2012-08-16
HU225233B1 (en) 2006-08-28

Similar Documents

Publication Publication Date Title
AR015947A1 (es) Una forma 1 polimorfica (-)-4-[4-[4-[4-[[(2r-cis]-5-(2,4-difluorfenil)tetrahidro-5-(1h-1,2,4-triazol-1-ilmetil)furan-3-il]-metoxi]fenil]-1-piperazinil]fenil-2,4-dihidro-2-[(s)-1-etil-2-(s)-hidroxipropil]-3h-1,2,4-triazol-3-ona, composicion farmaceutica que la contiene y su uso para preparar un medic
FR21C1010I2 (fr) 2,4,di-(hetero-) arylamino (-oxy)-5 pyrimidines substitutees utilisees comme agents antineoplasiques
KR970705558A (ko) 항진균 활성을 갖는 신규 피리미돈 유도체(new pyrimidone derivatives with antifungal activity)
JP2001519346A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HUP9901820A2 (hu) 4-Amino-pirimidin-származékok, ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk és eljárás előállításukra
NO986087L (no) Oralt preparat omfattende en antifungal triazolforbindelse
KR910021398A (ko) 트리아졸 항진균제
WO2006010574A1 (en) Piperazine derivatives for the treatment of female sexual disorders
SI3075726T1 (en) DERIVATIVES OF UREA OR ITS PHARMACOLOGICAL RECRUITABLE SALTS USED AS FORMIL PEPTIDAL RECEPTOR LIKE 1 (FPRL-1) AGONISTS
ES8505364A1 (es) Un procedimiento para la preparacion 1-imidazoles y 1h-1, 2, 4-triazoles
KR890014500A (ko) 트리아졸 유도체, 그의 제법 및 살균제로서의 그의 용도
IL70197A0 (en) Hydroxyalkyl-azolyl derivatives substituted by heterocyclic substituents,their preparation and their use as fungicides
HUT50333A (en) Process for producing pharmaceutical compositions comprising 1h-imidazoles and 1h-1,2,4-triazoles as active ingredient and process for producing the active ingredients
NO991384L (no) Substituerte heterocykler som anti-tumormidler
HUP9903420A2 (hu) Flukonazol felhasználása rákos megbetegedések és vírusos fertőzések kezelésére alkalmazható gyógyszerkészítmények előállítására
EP0829478A2 (en) N-Benzylimidazolium and N-benzyltriazolium derivatives, their preparation and their use as antifungal and antimycotic agents
KR950032147A (ko) 아실화된 아미노알칸이미다졸 및 -트리아졸
HUP9904265A2 (hu) Fokozott biológiai hasznosulású gombaellenes gyógyászati készítmény
RU97115290A (ru) Соединения азола, способ получения указанных соединений и их применение
JP2004520329A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP2004535427A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TH61733B (th) คริสตัลไลน์ แอนตีฟังกัล โพลีมอร์ฟ
RU2002135617A (ru) Хиназолиновые производные для лечения опухолей
KR940019692A (ko) 신규의 경구 활성 항진균제
TH17753B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
FC Refusal